- Home
- BHF vs CRNX Comparison
BHF vs CRNX Comparison
Compare BHF & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHF
- CRNX
- Stock Information
- Founded
- BHF 2016
- CRNX 2008
- Country
- BHF United States
- CRNX United States
- Employees
- BHF N/A
- CRNX N/A
- Industry
- BHF Life Insurance
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- BHF Finance
- CRNX Health Care
- Exchange
- BHF Nasdaq
- CRNX Nasdaq
- Market Cap
- BHF 2.8B
- CRNX 2.8B
- IPO Year
- BHF N/A
- CRNX 2018
- Fundamental
- Price
- BHF $50.21
- CRNX $30.99
- Analyst Decision
- BHF Hold
- CRNX Strong Buy
- Analyst Count
- BHF 10
- CRNX 8
- Target Price
- BHF $57.40
- CRNX $74.86
- AVG Volume (30 Days)
- BHF 911.2K
- CRNX 812.5K
- Earning Date
- BHF 08-07-2025
- CRNX 08-07-2025
- Dividend Yield
- BHF N/A
- CRNX N/A
- EPS Growth
- BHF N/A
- CRNX N/A
- EPS
- BHF 8.45
- CRNX N/A
- Revenue
- BHF $8,610,000,000.00
- CRNX $760,000.00
- Revenue This Year
- BHF $41.64
- CRNX $402.02
- Revenue Next Year
- BHF $2.59
- CRNX $771.03
- P/E Ratio
- BHF $5.87
- CRNX N/A
- Revenue Growth
- BHF 165.09
- CRNX N/A
- 52 Week Low
- BHF $40.00
- CRNX $24.10
- 52 Week High
- BHF $64.12
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- BHF 42.09
- CRNX 49.74
- Support Level
- BHF $48.55
- CRNX $30.44
- Resistance Level
- BHF $51.07
- CRNX $33.28
- Average True Range (ATR)
- BHF 1.57
- CRNX 1.43
- MACD
- BHF 0.17
- CRNX -0.05
- Stochastic Oscillator
- BHF 53.26
- CRNX 43.31
About BHF Brighthouse Financial Inc.
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.